Charcot Foot
CIM Case: Charcot Foot
Clinical Scenario
Patient: 60-year-old female Presentation: Right foot swelling and redness developing over 1 week, minimal pain, has been walking on it, noticed "warm feeling" in foot Relevant history: Type 2 diabetes for 15 years, on oral hypoglycaemics and insulin, HbA1c 9.2% (poorly controlled), peripheral neuropathy diagnosed 5 years ago, bilateral cataracts (diabetic retinopathy), previous left foot ulcer healed with conservative treatment Examination findings:
- Right midfoot significantly swollen and erythematous
- Increased warmth compared to left foot (>2°C difference by infrared thermometer)
- Loss of medial longitudinal arch (early rocker-bottom deformity)
- Peripheral pulses palpable bilaterally (dorsalis pedis, posterior tibial)
- Absent protective sensation (10g monofilament negative at all sites)
- Absent ankle reflexes bilaterally
- No open wounds or ulceration
- No purulent discharge
- Probe to bone not applicable (no wound)
- Able to weight-bear but with antalgic gait
- Left foot shows healed plantar ulcer scar
Investigations Provided
Laboratory Results
| Test | Result | Normal Range | Interpretation |
|---|---|---|---|
| Hb | 118 g/L | 115-160 g/L | Normal |
| WCC | 8.2 ×10⁹/L | 4-11 ×10⁹/L | Normal (argues against infection) |
| Platelets | 245 ×10⁹/L | 150-400 ×10⁹/L | Normal |
| ESR | 18 mm/hr | <20 mm/hr | Normal |
| CRP | 12 mg/L | <5 mg/L | Mildly elevated (can occur in acute Charcot) |
| HbA1c | 9.2% | <6.5% | Poorly controlled diabetes |
| Fasting glucose | 11.2 mmol/L | 3.5-5.5 mmol/L | Elevated |
| Creatinine | 145 μmol/L | 60-110 μmol/L | Mildly elevated (diabetic nephropathy) |
| eGFR | 48 mL/min | >90 mL/min | Stage 3a CKD |
| Uric acid | 0.38 mmol/L | 0.15-0.45 mmol/L | Normal (excludes gout) |
| Procalcitonin | 0.1 ng/mL | <0.5 ng/mL | Normal (argues against bacterial infection) |
Imaging
Image 1: Weight-bearing AP and Lateral Foot Radiographs
Radiological features:
- Fragmentation of the tarsometatarsal (Lisfranc) joints
- Subluxation at tarsometatarsal articulation
- Subchondral sclerosis and bone debris
- Joint effusion with soft tissue swelling
- Early collapse of medial longitudinal arch
- No sequestrum or involucrum (favours Charcot over osteomyelitis)
- No gas in soft tissues
Anatomical location: Midfoot (Brodsky Type 1, Sanders/Frykberg Pattern II)
Image 2: MRI Foot with Gadolinium (if obtained)
MRI findings:
- Bone marrow oedema in navicular, cuneiforms, and metatarsal bases
- Periarticular soft tissue oedema
- Joint effusions at Lisfranc joints
- No rim-enhancing fluid collection (argues against abscess)
- No sinus tract
- Subchondral bone changes without cortical destruction pattern typical of osteomyelitis
- Ghost sign negative (intact cortex)
Questions & Model Answers
What is the differential diagnosis and how do you distinguish Charcot neuroarthropathy from infection?
Describe the classification systems for Charcot neuroarthropathy.
What is the pathophysiology of Charcot neuroarthropathy?
How would you manage this patient's acute Charcot foot?
The patient presents 2 years later with a rocker-bottom deformity and recurrent plantar ulcer. What are your surgical options?
What is the prognosis and how do you counsel this patient about long-term outcomes?
Key Teaching Points
Pattern Recognition
This pattern suggests Charcot Neuroarthropathy:
- Diabetic patient with peripheral neuropathy
- Warm, swollen, erythematous foot
- Relatively painless (neuropathy)
- Intact skin (no ulcer or wound)
- Midfoot involvement
- Normal or only mildly elevated inflammatory markers
- Radiographic fragmentation without sequestrum
Distinguish from Osteomyelitis:
| Feature | Charcot | Osteomyelitis |
|---|---|---|
| Skin integrity | Usually intact | Usually wound/ulcer |
| Probe to bone | N/A | Positive |
| WCC | Normal | Elevated |
| Procalcitonin | Normal | Elevated |
| Location | Midfoot most common | Under ulcer |
Critical Management Points
- Early diagnosis is key - before significant collapse occurs
- Offloading is the mainstay - TCC or non-removable walker
- Don't confuse with infection - both can have warmth and erythema
- Long treatment duration - 6-12 months offloading
- Lifelong surveillance - contralateral foot at risk
- Surgery for deformity/ulceration - not primary treatment
Common Examiner Follow-ups
Q: "How do you monitor response to treatment?"
Monitoring parameters:
- Temperature difference: Should decrease to <2°C
- Swelling: Progressive reduction
- Serial X-rays: Transition from fragmentation to coalescence
- Clinical examination: Resolution of acute signs
Transition to Stage 2 (coalescence) typically takes 3-6 months. This is when gradual weight-bearing can begin.
Q: "What is the evidence for bisphosphonates in Charcot?"
Evidence for bisphosphonates:
- Theoretical rationale: Reduce osteoclast activity, prevent bone resorption
- Jude et al. (2001): Pamidronate reduced bone turnover markers
- Recent trials: Mixed results, no clear clinical benefit demonstrated
- Current practice: Not routinely used, consider in refractory cases
The mainstay of treatment remains offloading. Bisphosphonates are not standard of care.
Q: "What if MRI shows changes consistent with both Charcot and osteomyelitis?"
This is challenging - "overlap" cases:
- Charcot with secondary osteomyelitis: Can occur if ulcer develops
- Ghost sign: Absent bone marrow on T1 with absent cortex suggests osteomyelitis
- Sinus tract: Strongly suggests osteomyelitis
- Response to offloading: Charcot improves; osteomyelitis progresses
If doubt:
- Bone biopsy for culture and histology
- Consider tagged WBC scan
- Trial of offloading with close monitoring
- Multidisciplinary discussion
Q: "How does Charcot affect surgical planning for foot and ankle procedures?"
Considerations:
- Higher non-union rate - impaired bone healing
- Higher infection rate - diabetic microvasculature
- Need for super constructs - extend fixation, use stronger implants
- Longer healing times - extended non-weight-bearing
- Risk of triggering Charcot - any surgery can trigger acute Charcot in at-risk feet
Prophylactic measures:
- Optimise glycaemic control preoperatively
- Prolonged non-weight-bearing
- Close monitoring post-surgery
- Consider protected weight-bearing longer than standard protocols
Related Topics
- Diabetic Foot Ulcers
- Osteomyelitis
- Midfoot Arthrodesis
- Peripheral Neuropathy
- Total Contact Casting
- Diabetic Foot Infections